Your session is about to expire
← Back to Search
Epclusa for Hepatitis C (KeY Treat Trial)
KeY Treat Trial Summary
This trial is testing whether making it easier for people with hepatitis C to get treatment will improve their health in Perry County, Kentucky.
KeY Treat Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowKeY Treat Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.KeY Treat Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: HCV Positive Study Participants
- Group 2: Control (Pike County)
Frequently Asked Questions
How many participants have been recruited to take part in this trial?
"Affirmative. According to clinicaltrials.gov, this medical study which was originally posted on September 23rd 2019 is actively enrolling participants. Approximately 900 individuals need to be recruited from one site for the trial's success."
Are individuals currently being recruited to take part in this trial?
"According to clinicaltrials.gov, this study is currently in the process of recruiting participants who meet its criteria; it was initially published on September 23rd 2019 and most recently updated on September 25th 2022."
Could you please elucidate the potential perils of using Sofosbuvir/velpatasvir (Epclusa®)?
"Data from the Phase 4 clinical trial supports that Sofosbuvir/velpatasvir (Epclusa®) is safe, and thus our team at Power gave it a score of 3."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger